Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Mar 21;8(1):135.
doi: 10.1038/s41392-023-01390-y.

FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection

Affiliations
Comment

FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection

Zhe Li et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The schematic diagram of FXR signaling controlling ACE2 expression. Left, CDCA binds to and activates FXR, which further induces ACE2 expression. Right, FXR inhibitors, including UDCA and the ZGG, diminish ACE2 expression and thereby reduce the susceptibility to SARS-CoV-2 infection

Comment on

  • FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.
    Brevini T, Maes M, Webb GJ, John BV, Fuchs CD, Buescher G, Wang L, Griffiths C, Brown ML, Scott WE 3rd, Pereyra-Gerber P, Gelson WTH, Brown S, Dillon S, Muraro D, Sharp J, Neary M, Box H, Tatham L, Stewart J, Curley P, Pertinez H, Forrest S, Mlcochova P, Varankar SS, Darvish-Damavandi M, Mulcahy VL, Kuc RE, Williams TL, Heslop JA, Rossetti D, Tysoe OC, Galanakis V, Vila-Gonzalez M, Crozier TWM, Bargehr J, Sinha S, Upponi SS, Fear C, Swift L, Saeb-Parsy K, Davies SE, Wester A, Hagström H, Melum E, Clements D, Humphreys P, Herriott J, Kijak E, Cox H, Bramwell C, Valentijn A, Illingworth CJR; UK-PBC Consortium; Dahman B, Bastaich DR, Ferreira RD, Marjot T, Barnes E, Moon AM, Barritt AS 4th, Gupta RK, Baker S, Davenport AP, Corbett G, Gorgoulis VG, Buczacki SJA, Lee JH, Matheson NJ, Trauner M, Fisher AJ, Gibbs P, Butler AJ, Watson CJE, Mells GF, Dougan G, Owen A, Lohse AW, Vallier L, Sampaziotis F. Brevini T, et al. Nature. 2023 Mar;615(7950):134-142. doi: 10.1038/s41586-022-05594-0. Epub 2022 Dec 5. Nature. 2023. PMID: 36470304 Free PMC article.

References

    1. Brevini T, et al. FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. Nature. 2023;615:134–142. doi: 10.1038/s41586-022-05594-0. - DOI - PMC - PubMed
    1. Cao Y, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602:657–663. doi: 10.1038/s41586-021-04385-3. - DOI - PMC - PubMed
    1. Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty. 2020;9:45. doi: 10.1186/s40249-020-00662-x. - DOI - PMC - PubMed
    1. Kotb MA. Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode. Int. J. Mol. Sci. 2012;13:8882–8914. doi: 10.3390/ijms13078882. - DOI - PMC - PubMed
    1. Martens, K., Vanhulle, E., Viskens, A., Hellings, P. W. & Vermeire, K. Fluticasone propionate suppresses the SARS-CoV-2 induced increase in respiratory epithelial permeability in vitro. Rhinology (2022). 10.4193/Rhin22.223. - PubMed

Publication types

Substances